ZA200900197B - Anti-cocaine compositions and treatment - Google Patents

Anti-cocaine compositions and treatment

Info

Publication number
ZA200900197B
ZA200900197B ZA200900197A ZA200900197A ZA200900197B ZA 200900197 B ZA200900197 B ZA 200900197B ZA 200900197 A ZA200900197 A ZA 200900197A ZA 200900197 A ZA200900197 A ZA 200900197A ZA 200900197 B ZA200900197 B ZA 200900197B
Authority
ZA
South Africa
Prior art keywords
cocaine
compositions
treatment
cocaine compositions
Prior art date
Application number
ZA200900197A
Other languages
English (en)
Inventor
Donald Landry
Chang-Guo Zhan
James H Woods
Roger Sunahara
Diwahar L Narasimhan
Joanne Macdonald
Victor Yang
Mei-Chuan Holden Ko
Shi-Xian Deng
John J Tesmer
Tien-Yi Lee
Young Min Kwon
Daquan Gao
Original Assignee
Univ Columbia
Univ Kentucky Res Found
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia, Univ Kentucky Res Found, Univ Michigan filed Critical Univ Columbia
Publication of ZA200900197B publication Critical patent/ZA200900197B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C12Y301/01—Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01084—Cocaine esterase (3.1.1.84)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
ZA200900197A 2006-07-10 2007-07-10 Anti-cocaine compositions and treatment ZA200900197B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81956906P 2006-07-10 2006-07-10

Publications (1)

Publication Number Publication Date
ZA200900197B true ZA200900197B (en) 2010-10-27

Family

ID=38923847

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200900197A ZA200900197B (en) 2006-07-10 2007-07-10 Anti-cocaine compositions and treatment

Country Status (14)

Country Link
US (3) US8318156B2 (zh)
EP (1) EP2046368B1 (zh)
KR (2) KR20150055085A (zh)
CN (1) CN101583374B (zh)
AU (1) AU2007272955B2 (zh)
BR (1) BRPI0714380A2 (zh)
CA (1) CA2657246C (zh)
CO (1) CO6150185A2 (zh)
ES (1) ES2574088T3 (zh)
IL (1) IL196411A (zh)
MX (1) MX2009000418A (zh)
MY (1) MY162844A (zh)
WO (1) WO2008008358A2 (zh)
ZA (1) ZA200900197B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0714380A2 (pt) * 2006-07-10 2013-03-05 Univ Columbia composiÇÕes anticocaÍna e tratamento
MX2010000410A (es) 2007-07-10 2010-05-24 Univ Columbia Termoestabilizacion de proteinas.
US8501692B2 (en) 2009-12-14 2013-08-06 The Regents Of The University Of Michigan Compositions and methods for altering cocaine esterase activity
AR094481A1 (es) * 2013-01-15 2015-08-05 Teva Pharma Formulaciones de albu-bche (albúmina-butirilcolinesterasa), preparación y sus usos
US10160960B2 (en) 2013-08-06 2018-12-25 The Trustees Of Columbia University In The City Of New York Mutants of cocaine esterase
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
IT201900024493A1 (it) * 2019-12-18 2021-06-18 Irides S R L Ceppi di rhodococcus e marinomonas per il biorisanamento
CN113481182B (zh) * 2021-07-05 2022-11-15 杭州师范大学 可卡因酯酶突变体及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9115765D0 (en) * 1991-07-22 1991-09-04 Britt Adrian J Bacterial enzyme for cocaine detection
US5463028A (en) * 1992-04-03 1995-10-31 The Trustees Of Columbia University In The City Of New York Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents
US5730985A (en) 1994-06-13 1998-03-24 Governing Council Of The University Of Toronto Immunogens for the production of cocaine-hydrolyzing catalytic antibodies
TR200101549T2 (tr) 1998-12-02 2001-11-21 Pfizer Products Inc. p53-Familyasından bir proteinin yapısal kararlılığının canlandırılmasına yönelik metotlar.
BRPI0714380A2 (pt) * 2006-07-10 2013-03-05 Univ Columbia composiÇÕes anticocaÍna e tratamento
MX2010000410A (es) * 2007-07-10 2010-05-24 Univ Columbia Termoestabilizacion de proteinas.
US10160960B2 (en) * 2013-08-06 2018-12-25 The Trustees Of Columbia University In The City Of New York Mutants of cocaine esterase

Also Published As

Publication number Publication date
EP2046368A4 (en) 2010-02-10
ES2574088T3 (es) 2016-06-14
IL196411A0 (en) 2011-08-01
KR20090078324A (ko) 2009-07-17
CO6150185A2 (es) 2010-04-20
US20100034799A1 (en) 2010-02-11
IL196411A (en) 2015-10-29
WO2008008358A3 (en) 2008-12-24
CN101583374A (zh) 2009-11-18
MX2009000418A (es) 2009-08-12
US20160160195A1 (en) 2016-06-09
AU2007272955A1 (en) 2008-01-17
US8318156B2 (en) 2012-11-27
BRPI0714380A2 (pt) 2013-03-05
CN101583374B (zh) 2013-06-12
WO2008008358A2 (en) 2008-01-17
EP2046368A2 (en) 2009-04-15
CA2657246A1 (en) 2008-01-17
CA2657246C (en) 2017-10-31
MY162844A (en) 2017-07-31
KR20150055085A (ko) 2015-05-20
US9200265B2 (en) 2015-12-01
AU2007272955B2 (en) 2013-12-19
US20130136728A1 (en) 2013-05-30
EP2046368B1 (en) 2016-03-02

Similar Documents

Publication Publication Date Title
EP2086318A4 (en) NEUROPROTEKTIVE COMPOSITIONS AND METHOD
HK1134679A1 (zh) 用於治療感染的組合物和方法
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
HK1137670A1 (zh) 用於關節固定過程的組合物和方法
HK1125868A1 (en) Compositions and methods for treating bone
IL191072A0 (en) Therapeutic compositions and methods
EP2046936A4 (en) BIOCIDAL COMPOSITIONS AND METHODS
IL186963A0 (en) Methods and compositions for treating pain
EP2101731A4 (en) PROCESSES AND COMPOSITIONS WITH END OXIFES
EP1890712A4 (en) COMPOSITIONS AND METHODS FOR TREATING PAIN
IL198723A0 (en) Methods and compositions for therapeutic treatment
EP2049151A4 (en) METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
ZA200900140B (en) Methods and compositions for treating biofilms
IL196843A0 (en) Compositions and methods for the treatment of radiation proctosigmoitis
ZA201001616B (en) Cleaning and/or treatment compositions
IL196411A0 (en) Anti-cocaine compositions and treatment
EP2088865A4 (en) METHODS AND COMPOSITIONS AROUND GUGGULPHOSPHOLIPIDS
GB0617171D0 (en) Novel compositions and methods
PL2012805T3 (pl) Kompozycja lecznicza i jej zastosowanie
GB0718918D0 (en) Compositions and methods for treating skin conditions
EP1998753A4 (en) COMPOSITIONS FOR MAJOR DEPOSITION AND USES THEREOF
EP2029132A4 (en) ANTIHISTAMINE COMPOSITIONS AND THEIR USE
GB0614365D0 (en) Pharmaceutical compositions and their use
HK1129596A1 (zh) 治療疾病的方法和配方
GB0504657D0 (en) Compositions and methods of treatment